首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1424424

全球药品销售外包市场：按服务类型、按治疗领域、按最终用户、按地区

Global Pharmaceutical Contract Sales Outsourcing Market, By Service Type, By Therapeutic Area, By End User, By Geography

出版日期: 2024年01月12日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球医药合约外包 (CSO) 市场规模预计将从 2023 年的 85.992 亿美元增至 2030 年的 153.467 亿美元，预测期内复合年增长率为 8.6%。

报告范围		报告详情
基准年	2022年	2023/2024年市场规模	85.992 亿美元
实际资料	2018-2021	预测期	2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率：	8.60%	2030/2031价值预测	153.467 亿美元

图 1. 2023 年按地区分類的药品销售合约外包 (CSO) 的全球市场占有率(%)

近年来，全球医药合约外包（CSO）市场呈现出良好的成长动能。为了专注于药物研发，製药商越来越多地将销售和行销业务委託给专业的 CSO 供应商。 CSO 公司协助製药商优化销售业务、管理代理商拜访并确保促销符合监管指南。公民社会组织利用资料驱动的主导和技术解决方案来提高销售负责人的效率并扩大医生的覆盖范围。外包模式使製药公司能够获得专业知识并提高业务效率，而不会产生高昂的固定成本。这种具有成本效益的方法在寻求简化商业化活动的生物製药公司中越来越受欢迎。

市场动态：.

全球製药合约外包（CSO）市场是由生物製药公司优化营运成本和提高生产力的需求等因素推动的。此外，药品促销法规日益复杂（尤其是在美国），导致製药公司将其销售业务外包给熟悉合规框架的专业 CSO 提供者。此外，客户关係管理和资料分析的技术进步正在增加对外包销售业务的需求。然而，药品价格环境的波动以及部分地区医疗改革的不利为市场主体带来了挑战。此外，CSO 产业形势的整合也会影响顾客关係。新的商机在于扩展到非传统治疗领域并提供附加价值服务。

公司对简化销售流程和提高效率的需求不断增长，可能会进一步推动对销售计划/绩效分析软体的需求。例如，2023 年 11 月 7 日，数位科技公司Accenture和软体公司销售团队 Inc. 宣布合作，为生命科学公司建立由人工智慧 (AI) 驱动的云端服务。透过此次合作，Accenture将把生物医学研究产业和人工智慧技术的独特专业知识添加到销售团队的生命科学云中，创建新软体，帮助医疗技术、生物技术和製药公司提高效率。我们将为实现我们的目标做出贡献。使命。

本研究的主要特点

本报告对全球药品合约外包（CSO）市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年增长率。
它确定了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球合约销售业务(CSO) 市场的主要企业进行了分析。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球合约销售业务(CSO) 市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过在分析全球药品分销外包 (CSO) 市场时使用的各种策略矩阵来促进决策。

北美洲
美国
加拿大
欧洲
德国
英国
西班牙
法国
义大利
俄罗斯
其他欧洲国家
亚太地区
中国
印度
日本
澳洲
韩国
ASEAN
其他亚太地区
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中东
海湾合作委员会国家
以色列
其他中东地区
非洲
北非
中部非洲
南非

第9章竞争形势

公司简介
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company（TMAC）
- Ashfield Healthcare Communications Group
- GTS Solutions

第10章

参考
调查方法
关于出版商

简介目录

Product Code: CMI6549

The global pharmaceutical contract sales outsourcing (CSO) market size is expected to reach US$ 15,346.7 Mn by 2030, from US$ 8,599.2 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.6% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 8,599.2 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.60%	2030/2031 Value Projection:	US$ 15,346.7 Mn

Figure 1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share (%), By Region, 2023

Global Pharmaceutical Contract Sales Outsourcing Market - IMG1

The global pharmaceutical contract sales outsourcing (CSO) market has shown promising growth in recent years. Pharmaceutical manufacturers are increasingly outsourcing their sales and marketing operations to specialized CSO providers in order to focus on drug research and development. CSO firms assist drug makers in optimizing sales operations, managing representative visits, and ensuring promotional compliance with regulatory guidelines. They leverage data-driven insights and technological solutions to enhance sales representative effectiveness and expand physician reach. The outsourcing model enables pharmaceutical companies to access specialized expertise and achieve operational efficiencies without incurring high fixed costs. This cost-effective approach has thus gained traction among biopharma firms looking to streamline commercialization activities.

Market Dynamics:

The global pharmaceutical contract sales outsourcing (CSO) market is driven by factors such as the need of biopharma players to optimize sales costs and boost productivity. Growing complexity of drug promotion regulations particularly in the U.S. also prompts pharmaceutical companies to outsource sales operations to specialized CSO providers well-versed with compliance frameworks. Additionally, technological advancements in customer relationship management and data analytics are translating into increased demand for outsourced sales capabilities. However, volatility in drug pricing environments and unfavorable healthcare reforms in certain regions pose challenges to market players. Furthermore, consolidation in the CSO industry landscape impacts client relationships. Emerging opportunities lie in expansion into non-traditional therapeutic areas and offering value-added services around market access.

Increasing requirement for companies to streamline the sales process and achieve higher efficiency will further aid in the demand for sales planning/performance analytics software. For instance, on November 7, 2023, Accenture, a digital technology company, and Salesforce, Inc., a software company, announced the collaboration to build an Artificial intelligence (AI) powered cloud service for life sciences companies. Under the collaborations, Accenture added its own expertise both in the biomedical research industry and in artificial intelligence technologies to the Salesforce Life Sciences Cloud to help fulfill the new software's mission of making medtech, biotech, and pharma companies more efficient.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical contract sales outsourcing (CSO) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical contract sales outsourcing (CSO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical contract sales outsourcing (CSO) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical contract sales outsourcing (CSO) market

Detailed Segmentation:

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type
- Personal Promotion
- Non-personal Promotion
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area
- Cardiovascular Disorders
- Oncology
- Metabolic Disorders
- Neurology
- Orthopedic Diseases
- Infectious Diseases
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User
- Biopharmaceutical Companies
- Medical Device Companies
- Generic Companies
- Others
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Top Companies in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market:
- IQVIA Inc.
- Syneos Health Inc.
- Parexel International Corporation
- PPD
- ICON plc
- Publicis Touchpoint Solutions, Inc.
- PRA Health Sciences, Inc.
- The Medical Affairs Company (TMAC)
- Ashfield Healthcare Communications Group
- GTS Solutions

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Service Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Digital technology adoption
- Access to care disparities
- Population health initiatives
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Service Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Non-personal Promotion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Therapeutic Area, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Orthopedic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Generic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profile
- IQVIA Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Syneos Health Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Parexel International Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- PPD
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- ICON plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Publicis Touchpoint Solutions, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Strategies
- PRA Health Sciences, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- The Medical Affairs Company (TMAC)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Ashfield Healthcare Communications Group
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GTS Solutions
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球药品销售外包市场：按服务类型、按治疗领域、按最终用户、按地区